Abstract |
Melanoma, a potentially lethal skin cancer, is widely thought to be immunogenic in nature. While there has been much focus on T cell-mediated immune responses, limited knowledge exists on the role of mature B cells. We describe an approach, including a cell-based ELISA, to evaluate mature IgG antibody responses to melanoma from human peripheral blood B cells. We observed a significant increase in antibody responses from melanoma patients (n = 10) to primary and metastatic melanoma cells compared to healthy volunteers (n = 10) (P<0.0001). Interestingly, we detected a significant reduction in antibody responses to melanoma with advancing disease stage in our patient cohort (n = 21) (P<0.0001). Overall, 28% of melanoma patient-derived B cell cultures (n = 1,800) compared to 2% of cultures from healthy controls (n = 600) produced antibodies that recognized melanoma cells. Lastly, a patient-derived melanoma-specific monoclonal antibody was selected for further study. This antibody effectively killed melanoma cells in vitro via antibody-mediated cellular cytotoxicity. These data demonstrate the presence of a mature systemic B cell response in melanoma patients, which is reduced with disease progression, adding to previous reports of tumor-reactive antibodies in patient sera, and suggesting the merit of future work to elucidate the clinical relevance of activating humoral immune responses to cancer.
|
Authors | Amy E Gilbert, Panagiotis Karagiannis, Tihomir Dodev, Alexander Koers, Katie Lacy, Debra H Josephs, Pooja Takhar, Jenny L C Geh, Ciaran Healy, Mark Harries, Katharine M Acland, Sarah M Rudman, Rebecca L Beavil, Philip J Blower, Andrew J Beavil, Hannah J Gould, James Spicer, Frank O Nestle, Sophia N Karagiannis |
Journal | PloS one
(PLoS One)
Vol. 6
Issue 4
Pg. e19330
(Apr 29 2011)
ISSN: 1932-6203 [Electronic] United States |
PMID | 21559411
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Immunoglobulin G
|
Topics |
- Antibodies, Monoclonal
(chemistry)
- Antibodies, Neoplasm
(chemistry)
- B-Lymphocytes
(immunology)
- Case-Control Studies
- Cell Line
- Cell Line, Tumor
- Cohort Studies
- Disease Progression
- Enzyme-Linked Immunosorbent Assay
(methods)
- Fibroblasts
(metabolism)
- Humans
- Immune System
- Immunoglobulin G
(blood, chemistry)
- Immunohistochemistry
(methods)
- Melanoma
(blood, immunology, therapy)
- Time Factors
|